224 related articles for article (PubMed ID: 15135669)
1. Dacron femoral-popliteal bypass grafts in good-risk claudicant patients.
Johansen KH; Watson JC
Am J Surg; 2004 May; 187(5):580-4; discussion 584. PubMed ID: 15135669
[TBL] [Abstract][Full Text] [Related]
2. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
Rychlik IJ; Davey P; Murphy J; O'Donnell ME
J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
[TBL] [Abstract][Full Text] [Related]
3. Graft type for femoro-popliteal bypass surgery.
Ambler GK; Twine CP
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD001487. PubMed ID: 29429146
[TBL] [Abstract][Full Text] [Related]
4. Results of infrainguinal revascularization with bypass surgery using a heparin-bonded graft for disabling intermittent claudication due to femoropopliteal occlusive disease.
Piffaretti G; Dorigo W; Ottavi P; Pulli R; Castelli P; Pratesi C;
J Vasc Surg; 2019 Jul; 70(1):166-174.e1. PubMed ID: 31113719
[TBL] [Abstract][Full Text] [Related]
5. Popliteal-to-distal bypass: identifying risk factors associated with limb loss and graft failure.
Galaria II; Surowiec SM; Tanski WJ; Fegley AJ; Rhodes JM; Illig KA; Shortell CK; Green RM; Davies MG
Vasc Endovascular Surg; 2005; 39(5):393-400. PubMed ID: 16193211
[TBL] [Abstract][Full Text] [Related]
6. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
8. The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure.
Brumberg RS; Back MR; Armstrong PA; Cuthbertson D; Shames ML; Johnson BL; Bandyk DF
J Vasc Surg; 2007 Dec; 46(6):1160-6. PubMed ID: 17920227
[TBL] [Abstract][Full Text] [Related]
9. The Debatable Choice of Iliac Inflow Source for Redo Femoropopliteal and Infrapopliteal Bypass.
Gabrielli R; Ciocca F; Dante A; Musilli A; Maiorano M; Ventura M
Ann Vasc Surg; 2018 Oct; 52():316.e15-316.e19. PubMed ID: 29886210
[TBL] [Abstract][Full Text] [Related]
10. Prosthetic above-knee femoropopliteal bypass for intermittent claudication.
Rosenthal D; Evans RD; McKinsey J; Seagraves MA; Lamis PA; Clark MD; Daniel WW
J Cardiovasc Surg (Torino); 1990; 31(4):462-8. PubMed ID: 2145288
[TBL] [Abstract][Full Text] [Related]
11. Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).
Neufang A; Espinola-Klein C; Dorweiler B; Messow CM; Schmiedt W; Vahl CF
J Vasc Surg; 2007 Aug; 46(2):280-8. PubMed ID: 17600663
[TBL] [Abstract][Full Text] [Related]
12. Dacron or ePTFE for femoro-popliteal above-knee bypass grafting: short- and long-term results of a multicentre randomised trial.
van Det RJ; Vriens BH; van der Palen J; Geelkerken RH
Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):457-63. PubMed ID: 19231253
[TBL] [Abstract][Full Text] [Related]
13. Factors Affecting Long-Term Results of Above-Knee Femoropopliteal Bypass: A Single-Center Contemporary Study.
De Santis F; Pattaro C; Mani G; Pramstaller PP; Loreni G; Martini G
Vasc Endovascular Surg; 2016 Feb; 50(2):72-9. PubMed ID: 26983664
[TBL] [Abstract][Full Text] [Related]
14. Results from a multicenter registry of heparin-bonded expanded polytetrafluoroethylene graft for above-the-knee femoropopliteal bypass.
Piffaretti G; Dorigo W; Castelli P; Pratesi C; Pulli R;
J Vasc Surg; 2018 May; 67(5):1463-1471.e1. PubMed ID: 29175037
[TBL] [Abstract][Full Text] [Related]
15. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
Assadian A; Eckstein HH;
J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
[TBL] [Abstract][Full Text] [Related]
16. Broad variation in prosthetic conduit use for femoral-popliteal bypass is not justified on the basis of contemporary outcomes favoring autologous great saphenous vein.
Humbarger O; Siracuse JJ; Rybin D; Stone DH; Goodney PP; Schermerhorn ML; Farber A; Jones DW;
J Vasc Surg; 2019 Nov; 70(5):1514-1523.e2. PubMed ID: 31147137
[TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
18. Femoropopliteal bypass with a compliant, composite polyurethane/Dacron graft: short-term results of a multicentre trial.
Dereume JP; van Romphey A; Vincent G; Engelmann E
Cardiovasc Surg; 1993 Oct; 1(5):499-503. PubMed ID: 8076085
[TBL] [Abstract][Full Text] [Related]
19. Long-term quality of life and mobility after prosthetic above-the-knee bypass surgery.
Bosma J; Turkçan K; Assink J; Wisselink W; Vahl AC
Ann Vasc Surg; 2012 Feb; 26(2):225-32. PubMed ID: 21945332
[TBL] [Abstract][Full Text] [Related]
20. Above-knee prosthetic femoropopliteal bypass for intermittent claudication. Results of the initial and secondary procedures.
Aune S; Laxdal E
Eur J Vasc Endovasc Surg; 2000 May; 19(5):476-80. PubMed ID: 10828227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
